Toll Free: 1-888-928-9744

Insulin Pumps - Medical Devices Pipeline Assessment, 2016

Published: May 9, 2016 | Pages: 107 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Insulin Pumps - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Insulin Pumps - Medical Devices Pipeline Assessment, 2016" provides an overview of Insulin Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Insulin Pumps under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Insulin Pumps under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
 Table of Contents
Table of Contents 2 1.1 List of Tables 5 1.2 List of Figures 7 2 Introduction 8 2.1 Insulin Pumps Overview 8 3 Products under Development 9 3.1 Insulin Pumps - Pipeline Products by Stage of Development 9 3.2 Insulin Pumps - Pipeline Products by Segment 10 3.3 Insulin Pumps - Pipeline Products by Territory 11 3.4 Insulin Pumps - Pipeline Products by Regulatory Path 12 3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date 13 3.6 Insulin Pumps - Ongoing Clinical Trials 14 4 Insulin Pumps - Pipeline Products under Development by Companies 15 4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development 15 4.2 Insulin Pumps - Pipeline Products by Stage of Development 16 5 Insulin Pumps Companies and Product Overview 17 5.1 Amrita Vishwa Vidyapeetham Company Overview 17 5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17 5.2 Andain, Inc Company Overview 19 5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 19 5.3 Cellnovo Ltd. Company Overview 21 5.3.1 Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21 5.4 CeQur SA Company Overview 25 5.4.1 CeQur SA Pipeline Products & Ongoing Clinical Trials Overview 25 5.5 ConvaTec Healthcare B S.a.r.l. Company Overview 27 5.5.1 ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 27 5.6 Debiotech S.A. Company Overview 28 5.6.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 28 5.7 Hospira, Inc. Company Overview 31 5.7.1 Hospira, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 5.8 Insulet Corporation Company Overview 33 5.8.1 Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview 33 5.9 InsuLine Medical Ltd. Company Overview 36 5.9.1 InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36 5.10 LifeScan, Inc. Company Overview 40 5.10.1 LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40 5.11 MedSolve Technologies, Inc. Company Overview 42 5.11.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42 5.12 Medtronic plc Company Overview 43 5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43 5.13 MicroPort Scientific Corporation Company Overview 47 5.13.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 47 5.14 NanoMed Ltd Company Overview 50 5.14.1 NanoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 50 5.15 Phluid Corporation Company Overview 51 5.15.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 51 5.16 Sensile Medical AG Company Overview 52 5.16.1 Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 52 5.17 SFC Fluidics LLC Company Overview 55 5.17.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 55 5.18 Spring Health Solutions Ltd. Company Overview 56 5.18.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56 5.19 Tandem Diabetes Care, Inc. Company Overview 57 5.19.1 Tandem Diabetes Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57 5.20 ViCentra B.V. Company Overview 59 5.20.1 ViCentra B.V. Pipeline Products & Ongoing Clinical Trials Overview 59 5.21 Ypsomed Holding AG Company Overview 60 5.21.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 60 6 Insulin Pumps- Recent Developments 63 6.1 Apr 28, 2016: Greatbatch Reports 2016 First Quarter Results 63 6.2 Apr 28, 2016: Tandem Diabetes Care Reports First Quarter 2016 Financial Results and Updates 2016 Guidance 65 6.3 Apr 13, 2016: New Data Shows Benefits of Medtronic Insulin Pumps for People with Type 2 Diabetes 66 6.4 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury's Recent Temporary and Proposed Regulations 67 6.5 Mar 17, 2016: Medtronic Proposes Proxy Access 67 6.6 Mar 14, 2016: DECN Subsidiaries Sue Johnson & Johnson and Several Divisions for Patent Infringement 67 6.7 Mar 14, 2016: Tandem Diabetes Care Announces Appointment of Dr. Henry Anhalt as Board Member 67 6.8 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 68 6.9 Feb 29, 2016: Greatbatch Reports 2015 Fourth Quarter and Full Year Results 69 6.10 Feb 25, 2016: Insulet Enters into Licensing Agreement with Mode AGC 72 6.11 Feb 24, 2016: Ypsomed expands the distribution of mylife OmniPod in Europe 73 6.12 Feb 24, 2016: Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results 73 6.13 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 74 6.14 Feb 02, 2016: Tandem Diabetes Care Expands Commercial Leadership 74 6.15 Jan 29, 2016: Liberty Medical to Acquire Neighborhood Diabetes from Insulet for USD5 Million 75 6.16 Jan 11, 2016: FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System For Use in Children 75 6.17 Jan 11, 2016: Medtronic and Chengdu Sign Insulin Pump Manufacturing Agreement 76 6.18 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 76 6.19 Jan 11, 2016: Greatbatch Provides Preliminary 2015 Revenue Results and 2016 Guidance 77 6.20 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved 77 6.21 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 78 6.22 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference 78 6.23 Nov 26, 2015: Two Subsidiaries of MicroPort Recognized as One of Shanghai's the First Group of High-tech Enterprise 80 6.24 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79 80 6.25 Nov 17, 2015: Tandem Diabetes Care Announces Retirement of Board Chairman Lonnie Smith; Dick Allen Appointed as Successor Chairman 80 6.26 Oct 29, 2015: Tandem Diabetes Care Reports Third Quarter 2015 Financial Results 81 6.27 Oct 29, 2015: Greatbatch Reports 2015 Third Quarter Results 82 6.28 Oct 13, 2015: Greatbatch Raises USD360 Million in Private Placement of 9.125% Notes Due 2023 84 6.29 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments 85 6.30 Sep 09, 2015: MicroPort Scientific Corporation Announce Leadership Changes in MicroPort Orthopedics Subsidiary and Membership Changes in CEC, IEC 85 6.31 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 86 6.32 Sep 01, 2015: MPSC New COO Appointment - Jason Zhang 89 6.33 Aug 26, 2015: Greatbatch Partners with Wireless Power Leader WiTricity to Provide Wireless Charging for Medical Devices 89 6.34 Aug 04, 2015: NICE draft guidance recommends integrated automatic glucose monitoring system for people with type 1 diabetes 90 6.35 Aug 04, 2015: Animas Collaborates with Tidepool to Integrate Insulin Pump Data to Open-Source Software Aiding Diabetes Management 91 6.36 Jul 30, 2015: Tandem Diabetes Care Enters into Co-Development Agreement with Dexcom 92 6.37 Jul 30, 2015: Greatbatch Reports 2015 Second Quarter Results 92 6.38 Jul 30, 2015: Tandem Diabetes Care Reports Second Quarter 2015 Financial Results 94 6.39 Jul 24, 2015: Medtronic MiniMed Recalls MiniMed 620G and 640G Insulin Pumps 95 6.40 Jun 19, 2015: cellnovo starts the expansion of its distribution network 95 6.41 Jun 08, 2015: BD Medical Partners with Medtronic for Infusion Set 96 6.42 Jun 08, 2015: Tandem Diabetes Care Announces t:simulator App Now Available for Android Devices 96 6.43 Jun 05, 2015: Algostim to be Renamed Nuvectra 96 6.44 Jun 03, 2015: Glooko Enters into Agreement with Dexcom 97 6.45 Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results 97 6.46 May 19, 2015: Tandem Diabetes Care Launches t:flex Insulin Pump 100 6.47 May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results 100 7 Appendix 104 7.1 Methodology 104 7.2 About GlobalData 106 7.3 Contact Us 107 7.4 Disclaimer 107
List of Tables
Table 1: Insulin Pumps - Pipeline Products by Stage of Development 9 Table 2: Insulin Pumps - Pipeline Products by Segment 10 Table 3: Insulin Pumps - Pipeline Products by Territory 11 Table 4: Insulin Pumps - Pipeline Products by Regulatory Path 12 Table 5: Insulin Pumps - Pipeline Products by Estimated Approval Date 13 Table 6: Insulin Pumps - Ongoing Clinical Trials 14 Table 7: Insulin Pumps Companies - Pipeline Products by Stage of Development 15 Table 8: Insulin Pumps - Pipeline Products by Stage of Development 16 Table 9: Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17 Table 10: MEMS-based Insulin Pump - Product Status 18 Table 11: MEMS-based Insulin Pump - Product Description 18 Table 12: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 19 Table 13: Gaia Med Diamond Insulin Pump - Product Status 19 Table 14: Gaia Med Diamond Insulin Pump - Product Description 19 Table 15: Gemini Pump - Product Status 20 Table 16: Gemini Pump - Product Description 20 Table 17: Cellnovo Ltd. Pipeline Products & Ongoing Clinical Trials Overview 21 Table 18: Cellnovo Wireless Insulin Pump System - Product Status 22 Table 19: Cellnovo Wireless Insulin Pump System - Product Description 22 Table 20: Cellnovo Ltd. - Ongoing Clinical Trials Overview 23 Table 21: Cellnovo Wireless Insulin Pump System - Crossover Evaluation of Glycemic Control Provided for Three Days by the Artificial Pancreas Diabeloop Compared to Conventional Treatment by External Insulin Pump in Patients with Type 1 Diabetes in Sedentary Position, Outstanding Meals and Physical Activity: DIABELOOP WP6.2 24 Table 22: CeQur SA Pipeline Products & Ongoing Clinical Trials Overview 25 Table 23: PaQ Insulin Delivery Device - Product Status 26 Table 24: PaQ Insulin Delivery Device - Product Description 26 Table 25: ConvaTec Healthcare B S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 27 Table 26: Patch Pump - Product Status 27 Table 27: Patch Pump - Product Description 27 Table 28: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 28 Table 29: Jewel Pump - Product Status 29 Table 30: Jewel Pump - Product Description 29 Table 31: JewelPUMP2 - Product Status 30 Table 32: JewelPUMP2 - Product Description 30 Table 33: Hospira, Inc. Pipeline Products & Ongoing Clinical Trials Overview 31 Table 34: Integrated Symbiq/EndoTool System - Product Status 32 Table 35: Integrated Symbiq/EndoTool System - Product Description 32 Table 36: Insulet Corporation Pipeline Products & Ongoing Clinical Trials Overview 33 Table 37: OmniPod - Humalog U200 - Product Status 34 Table 38: OmniPod - Humalog U200 - Product Description 34 Table 39: OmniPod - New Version - Product Status 35 Table 40: OmniPod - New Version - Product Description 35 Table 41: InsuLine Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36 Table 42: InsuPatch Device - Product Status 37 Table 43: InsuPatch Device - Product Description 37 Table 44: InsuLine Medical Ltd. - Ongoing Clinical Trials Overview 38 Table 45: InsuPatch Device - Warming up to Sensors: Does Site Warming Improve Continuous Glucose Monitor Performance 39 Table 46: LifeScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40 Table 47: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Status 41 Table 48: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Description 41 Table 49: MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42 Table 50: Freehand Patch Pump - Product Status 42 Table 51: Freehand Patch Pump - Product Description 42 Table 52: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43 Table 53: MiniMed 670G - Product Status 44 Table 54: MiniMed 670G - Product Description 44 Table 55: Medtronic plc - Ongoing Clinical Trials Overview 45 Table 56: MiniMed 670G - Multi-center, Randomized, Adaptive, Controlled Trial in Adult and Pediatric Patients with Type 1 Diabetes Using Hybrid Closed Loop System at Home 46 Table 57: MiniMed 670G - Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects with Type 1 Diabetes 46 Table 58: MiniMed 670G - Safety Evaluation of the Hybrid Closed Loop (HCL) System in Type 1 Diabetes 46 Table 59: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 47 Table 60: Angel Touch - Product Status 48 Table 61: Angel Touch - Product Description 48 Table 62: La Fenice V - Product Status 49 Table 63: La Fenice V - Product Description 49 Table 64: NanoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 50 Table 65: FMA Patch - Diabetes Mellitus - Product Status 50 Table 66: FMA Patch - Diabetes Mellitus - Product Description 50 Table 67: Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 51 Table 68: Ambulatory Diabetes Pump - Product Status 51 Table 69: Ambulatory Diabetes Pump - Product Description 51 Table 70: Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 52 Table 71: SenseBolus - Product Status 53 Table 72: SenseBolus - Product Description 53 Table 73: SensePatch SD - Product Status 54 Table 74: SensePatch SD - Product Description 54 Table 75: SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 55 Table 76: Disposable Insulin Patch Pump - Product Status 55 Table 77: Disposable Insulin Patch Pump - Product Description 55 Table 78: Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 56 Table 79: Spring Zone Hybrid Patch Pump - Product Status 56 Table 80: Spring Zone Hybrid Patch Pump - Product Description 56 Table 81: Tandem Diabetes Care, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57 Table 82: Next Generation t:slim Insulin Pump - Product Status 58 Table 83: Next Generation t:slim Insulin Pump - Product Description 58 Table 84: ViCentra B.V. Pipeline Products & Ongoing Clinical Trials Overview 59 Table 85: Kaleido Insulin Pump - Product Status 59 Table 86: Kaleido Insulin Pump - Product Description 59 Table 87: Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 60 Table 88: Lanzi - Product Status 61 Table 89: Lanzi - Product Description 61 Table 90: mylife YpsoPump - Next Version - Product Status 62 Table 91: mylife YpsoPump - Next Version - Product Description 62 Table 92: Glossary 105


List of Figures
Figure 1: Insulin Pumps - Pipeline Products by Stage of Development 9 Figure 2: Insulin Pumps - Pipeline Products by Segment 10 Figure 3: Insulin Pumps - Pipeline Products by Territory 11 Figure 4: Insulin Pumps - Pipeline Products by Regulatory Path 12 Figure 5: Insulin Pumps - Pipeline Products by Estimated Approval Date 13 Figure 6: Insulin Pumps - Ongoing Clinical Trials 14

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global PP (Polypropylene) nonwoven fabric market size is anticipated to be valued at USD 30.6 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing usage of hygiene products such as incontinence products and baby diapers is

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliab

Read More...

Global heat transfer fluids market size is likely to be valued at USD 3.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing demand for for heat recovery management in industries such as metal processing, pharmaceutica

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify